Featured Content

Join a dedicated community at the Pharma Contract Manufacturing conference. We provide a secure environment to network, share insights, and overcome these hurdles. Our exclusive premium pass allows you to elevate your brand and forge lasting connections. Download now to see what our vendor-pass includes.

Explore the highlights from the 2025 Pharma Contract Manufacturing Conference!

Read more and discover:

• Audience overview and attending organisations
• Our esteemed 2025 speaker faculty
• Top sessions and key takeaways
• Testimonials from attendees
• Our 2024 sponsors
• What's next for Pharma Contract Manufacturing!

The pharmaceutical industry is undergoing a rapid transformation, with Contract Manufacturing Organisations (CMOs) and Contract Development and Manufacturing Organisations (CDMOs) playing an increasingly vital role. Ahead of the Pharma Contract Manufacturing Summit 2025, Pharma IQ has put together a comprehensive market report, that delves into the trends, challenges, and opportunities shaping the future of pharmaceutical manufacturing.

Why Download This Report? This resource provides actionable insights for industry professionals navigating the complexities of pharmaceutical manufacturing. From building resilient supply chains to achieving sustainability goals, the report serves as a roadmap for optimising partnerships, operations, and compliance.

Download the report now to explore how you can stay ahead in a rapidly evolving market.

Key takeaways include: 

• Market Insights: Learn how the global CMO/CDMO market is projected to reach $310.9 billion by 2030, driven by demand for outsourcing and innovative drugs.
• Digital Transformation: Discover how AI, IoT, and smart manufacturing are revolutionising operational efficiency and regulatory compliance.
• Sustainability: Explore how green chemistry, carbon neutrality, and sustainable packaging are redefining industry standards.
• Geopolitical Complexities: Understand how regulations like the BIOSECURE Act and regional strategies are reshaping supply chain resilience.
• Innovation: Learn about the role of additive manufacturing, predictive analytics, and lights-out manufacturing in driving future growth.

If you manage external manufacturing, quality oversight, or supply continuity, you know the pressure: one late update, one missed signal, or one unspoken issue can derail timelines, compliance, and patient supply.

This interview with Marta Ferrer, External Supply QA Manager at Sandoz, is designed to support the challenges you face every day. Marta focuses on what leaders consistently tell us they need most: real-world clarity on how to build CMO relationships that stay transparent, aligned, and responsive under pressure.

Her insights help you anticipate risks earlier, strengthen communication, and identify when a partnership is positioning you for success, or quietly putting your supply chain at risk.

In this interview, you’ll gain practical guidance on:

• What to look for when assessing a CMO’s agility, responsiveness, and problem-solving behaviour.
• How to reduce your oversight burden by encouraging proactive communication instead of reactive updates.
• The digital and AI-enabled tools are already helping leaders reduce deviations and improve quality and reliability.
• What truly differentiates a long-term, dependable partnership from one that creates more work than value.

Download the interview now if you’re focused on strengthening supply continuity, ensuring audit readiness, and building partnerships that make your work easier not riskier.

When selecting partners, meeting stringent sustainability criteria along entire pharmaceutical supply chains has far-reaching environmental, economic and reputational benefits. Whilst adding a sustainability criteria to the bidding process is a positive one for driving more responsible operations across the entire pharmaceutical industry, it simultaneously amplifies the complexity of selecting a Contract Manufacturing Organization (CMO).

Unlock the report to delve into vital statistics and expert insights, covering:

• Stringent selection criteria: understand the pivotal role stringent criteria play in shaping responsible and sustainable partnerships
• Bottom line benefits: explore the tangible economic advantages that sustainable practices bring to the forefront of your pharmaceutical operations
• Technology for greener supply chains: navigate the latest innovations driving sustainability in pharmaceutical supply chains and stay ahead in the industry

Topped up with expert commentary from industry leaders: Philip Coetzee, Director CMO Management, Daiichi Sankyo and Gregory Vanderwinden, Associate Director – External Manufacturing EU, MSD.

Elevate your CMO selection process and lead the way towards a greener, more sustainable pharmaceutical future.  Access the report now.

Pharma-CMO alliances are facing unprecedented strain. Between geopolitical instability, capacity constraints, and rising quality expectations, the need for transparent, collaborative partnerships has never been more urgent.

In this exclusive interview, Kyriakos Kansos and George Ntortas, Partners, Fuliginous Management Consulting, share actionable strategies on how both pharma companies and CDMOs can move beyond transactional relationships and build alliances that are resilient, responsive, and future-ready.

Whether you manage external supply chains, strategic sourcing, or contract manufacturing partnerships, this conversation delivers real-world insights from decades of hands-on experience advising global manufacturing leaders.

Download this interview to learn more about:

• How alignment and communication across all functions, from QA to Finance, create the foundation for agile partnerships.
• Why shared visibility and ownership are the defining traits of resilient pharma–CMO alliances.
• How to balance tactical pressures with strategic goals to ensure today’s decisions strengthen tomorrow’s collaborations. 

Download the full interview now and discover how to turn fragile partnerships into agile, future-ready alliances.

As pharmaceutical businesses worldwide become more aware of the importance of meeting sustainability goals, it is inevitable that this will become a consideration when selecting a contract manufacturing organisation (CMO) or contract development and manufacturing organisation (CDMO). But it’s important to ensure that meeting sustainability goals when collaborating with external partners is genuine rather than just greenwashing.

That's why ahead of Pharma Contract Manufacturing 2024 we have collated exclusive insights on CMO Selection - Making Sustainability a Top Priority.

Access the infographic and dive into:

• The Top 5 considerations for sustainable CMO selection
• Key questions for the selection process
• Changing the culture strategy
• Examining your Scope 3 emissions
• Real-world examples of setting measurable targets
• Looking ahead: The big picture benefits

This exclusive interview with Dr. Ulrich Rümenapp, Senior Biotech Program Lead at Bayer AG, delves into the key strategies for biotech manufacturing success.

For pharma professionals involved in biotech manufacturing, this interview offers actionable insights on balancing quality, cost, and control. Gain expert perspectives on how to leverage specialised partnerships, maintain compliance, and navigate the complexities of biotech production for future-ready manufacturing strategies.

Present your boss with this customizable letter detailing the reasons why you should attend Pharma Contract Manufacturing 2026 from 23rd - 25th March 2026, in Berlin, Germany. Just download the letter template below, adjust as necessary (or edit as needed) and submit! We hope to welcome you there!

Ahead of the Pharma Contract Manufacturing Summit 2023, Pharma IQ spoke exclusively to David Berry, Head of Digital Business Systems - Pharma, CPI about connecting automation to a QP dashboard at the MMIC, to help you discover new opportunities and solutions to your current pharma manufacturing challenges. 

Fill in the form below to access David's exclusive insights >>>